Asosiy kontentga oʻtish
Boshqa

RoB 2: a revised tool for assessing risk of bias in randomised trials

Jonathan A C SterneNIHR Bristol Biomedical Research Centre, Bristol, UKJelena SavovićNIHR CLAHRC West, University Hospitals Bristol NHS Foundation Trust, Bristol, UKMatthew J. PageSchool of Public Health and Preventive Medicine, Monash University, Melbourne, AustraliaRoy G. ElbersPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol BS8 2BN, UKNatalie BlencowePopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol BS8 2BN, UKIsabelle BoutronCochrane France, Paris, FranceChristopher J CatesPopulation Health Research Institute, St George's, University of London, London, UKHung‐Yuan ChengPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol BS8 2BN, UKMark CorbettCentre for Reviews and Dissemination, University of York, York, UKSandra EldridgePragmatic Clinical Trials Unit, Centre for Primary Care and Public Health, Queen Mary University of London, UKJonathan EmbersonMRC Population Heath Research Unit, Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UKMiguel A. HernánDepartments of Epidemiology and Biostatistics, Harvard T H Chan School of Public Health, Harvard-MIT Division of Health Sciences of Technology, Boston, MA, USASally HopewellUniversity of OxfordAsbjørn HróbjartssonDepartment of Clinical Research, University of Southern Denmark, Odense, DenmarkDaniela R. JunqueiraDepartment of Emergency Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, CanadaPeter JüniApplied Health Research Centre, Li Ka Shing Knowledge Institute, St Michael's Hospital, Department of Medicine and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, CanadaJamie J KirkhamCentre for Biostatistics, University of Manchester, Manchester, UKToby J LassersonEditorial and Methods Department, Cochrane Central Executive, London, UKTianjing LiDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USAAlexandra McAleenanPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol BS8 2BN, UKBarnaby C ReevesTranslational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UKSasha ShepperdNuffield Department of Population Health, University of Oxford, Oxford, UKIan ShrierMcGill UniversityLesley StewartCentre for Reviews and Dissemination, University of York, York, UKKate TillingPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol BS8 2BN, UKIan R. WhiteMRC Clinical Trials Unit, University College London, London, UKPenny WhitingPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol BS8 2BN, UKJulian P. T. HigginsNIHR Bristol Biomedical Research Centre, Bristol, UK
2019en
ABI

Annotatsiya

Assessment of risk of bias is regarded as an essential component of a systematic review on the effects of an intervention. The most commonly used tool for randomised trials is the Cochrane risk-of-bias tool. We updated the tool to respond to developments in understanding how bias arises in randomised trials, and to address user feedback on and limitations of the original tool.

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar

16 ta iqtibos0 ta foydalanilgan manba